FDA approves generic versions of controversial OxyContin

OxyContin may now go generic, U.S. regulators have ruled, but only if Teva Pharmaceuticals and Endo Pharmaceutical Holdings, whose products were approved, take steps to prevent illegal use of the drug. OxyContin, a strong opioid painkiller, is made by Purdue Pharma, which instigated procedures to prevent abuse by users who crushed the pill and took it all at once to get a high instead of allowing it to be dispensed by a time-release method, as intended.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA